IT8720698A0 - Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer. - Google Patents

Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.

Info

Publication number
IT8720698A0
IT8720698A0 IT8720698A IT2069887A IT8720698A0 IT 8720698 A0 IT8720698 A0 IT 8720698A0 IT 8720698 A IT8720698 A IT 8720698A IT 2069887 A IT2069887 A IT 2069887A IT 8720698 A0 IT8720698 A0 IT 8720698A0
Authority
IT
Italy
Prior art keywords
adaptivity
treatment
pharmaceutical composition
senile dementia
alzheimer type
Prior art date
Application number
IT8720698A
Other languages
English (en)
Other versions
IT1205042B (it
Inventor
Umberto Cornelli
Thomas A Ban
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to IT20698/87A priority Critical patent/IT1205042B/it
Publication of IT8720698A0 publication Critical patent/IT8720698A0/it
Priority to US07/197,419 priority patent/US4956347A/en
Priority to DE8888201047T priority patent/DE3865099D1/de
Priority to AT88201047T priority patent/ATE67666T1/de
Priority to EP88201047A priority patent/EP0293974B1/en
Priority to ES198888201047T priority patent/ES2040323T3/es
Priority to JP63128581A priority patent/JPS6419021A/ja
Application granted granted Critical
Publication of IT1205042B publication Critical patent/IT1205042B/it
Priority to GR91401381T priority patent/GR3002802T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT20698/87A 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer IT1205042B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US07/197,419 US4956347A (en) 1987-05-28 1988-05-23 Use of sulfomucopolysaccharides in the treatment of Alzheimer-type senile dementia
DE8888201047T DE3865099D1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
AT88201047T ATE67666T1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
EP88201047A EP0293974B1 (en) 1987-05-28 1988-05-24 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia
ES198888201047T ES2040323T3 (es) 1987-05-28 1988-05-24 Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.
JP63128581A JPS6419021A (en) 1987-05-28 1988-05-27 Use of sulfomco polysaccharides for therapeutically treating alzheimer's senile dementia
GR91401381T GR3002802T3 (en) 1987-05-28 1991-09-26 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Publications (2)

Publication Number Publication Date
IT8720698A0 true IT8720698A0 (it) 1987-05-28
IT1205042B IT1205042B (it) 1989-03-10

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Country Status (8)

Country Link
US (1) US4956347A (it)
EP (1) EP0293974B1 (it)
JP (1) JPS6419021A (it)
AT (1) ATE67666T1 (it)
DE (1) DE3865099D1 (it)
ES (1) ES2040323T3 (it)
GR (1) GR3002802T3 (it)
IT (1) IT1205042B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
EP0392059B1 (de) * 1989-04-14 1993-09-15 Merz & Co. GmbH & Co. Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
CA2159326C (en) * 1993-03-29 2000-05-30 Robert Kisilevsky Method for treating amyloidosis
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
EP1039883A4 (en) * 1996-07-09 2001-09-26 Keith A Crutcher METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
EP1014996B1 (en) * 1997-08-28 2003-05-28 University of Washington Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
IT1312107B1 (it) 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
MX2007005507A (es) * 2004-11-12 2008-03-13 Neurochem Int Ltd Metodos y composiciones fluoradas para el tratamiento de padecimientos relacionados con amiloides.
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
WO2006085149A2 (en) * 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
AU2006342958A1 (en) * 2005-12-22 2007-11-08 Bellus Health (International) Limited Treatment of renal disorders, diabetic nephropathy and dyslipidemias
SI2089417T1 (sl) 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
MX2009006768A (es) * 2006-12-22 2009-08-31 Bellus Health Int Ltd Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
US20170100428A1 (en) * 2014-05-30 2017-04-13 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
ES2040323T3 (es) 1993-10-16
DE3865099D1 (de) 1991-10-31
GR3002802T3 (en) 1993-01-25
IT1205042B (it) 1989-03-10
JPS6419021A (en) 1989-01-23
EP0293974A1 (en) 1988-12-07
ATE67666T1 (de) 1991-10-15
EP0293974B1 (en) 1991-09-25
US4956347A (en) 1990-09-11

Similar Documents

Publication Publication Date Title
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
PT88423A (pt) Process for the preparation of oxadiazolyl-azabicycloheptanes for the treatment of senile dementia
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
FI881892A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
IT1203934B (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
FI886057L (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
GB2216412B (en) Interleukin-6 molecule for the treatment of bone-related diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
IT1224741B (it) Dispositivo per il trattamento delle malattie delle gengive
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
IT8848258A0 (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
IE890271L (en) Drugs for the treatment of senile dementia
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ITMI930966A0 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960509